A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease
Translational Stroke Research · 2026
DOI: 10.1007/s12975-026-01472-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, 2026. Verfasst von Dong Young Jeong und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Convergence Science and Technology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Adenosine Triphosphatases. Die Arbeit nennt 20 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF) grant, MSIT, Basic Science Research Program, NRF, Ministry of Education, Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
BACKGROUND: Ring finger protein 213 (RNF213) p.R4810K is a genetic susceptibility factor for intracranial arteriopathies. In patients with isolated intracranial arterial steno-occlusive disease (ICAD) without Moyamoya disease (MMD), we developed a phenotype-based triage score to prioritize RNF213 genotyping by enriching the p.R4810K carriage probability. METHODS: We retrospectively analyzed 753 patients with isolated ICAD involving the distal internal carotid artery or middle cerebral artery M1 segment who underwent RNF213 genotyping between January 2010 and November 2022, excluding definite MMD or significant extracranial steno-occlusion. A prespecified score incorporated anterior cerebral artery (ACA) laterality (0/1/2), tandem lesion burden ≥ 3 (0/1), and MMD family history (0/1; weighted ×4). Discrimination, prespecified thresholds (≥ 3 and ≥ 4), and bootstrap-corrected calibration were assessed, with external application in an independent cohort. RESULTS: RNF213 p.R4810K was identified in 289 patients (38.4%). MMD family history showed the strongest association with carriage (adjusted odds ratio [OR] 8.34, 95% confidence interval [CI]: 4.15-16.77, p < 0.001), followed by tandem burden ≥ 3 (adjusted OR 1.76, 95% CI: 1.15-2.69, p = 0.009) and ACA laterality (adjusted OR 1.74, 95% CI: 1.35-2.23, p < 0.001). The score showed moderate discrimination (internal area under the curve [AUC] 0.720; external AUC 0.708). A cutoff ≥ 3 restricted genotyping to 33.5% of patients while capturing 55.7% of carriers, reducing genotyping workload by 66.5%. A cutoff ≥ 4 increased the positive predictive value to 81.7% with 97.6% specificity. CONCLUSIONS: In clinically selected isolated ICAD, a phenotype-based score incorporating lesion distribution and family history may help prioritize RNF213 genotyping and improve genotyping yield in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Convergence Science and Technology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Electrical Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
- Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, Republic of Korea.
- Medical Device Innovation Center, Pohang University of Science and Technology, Pohang, Republic of Korea.
- Department of Convergence IT Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
Förderung
- National Research Foundation of Korea (NRF) grant, MSIT
- Basic Science Research Program, NRF, Ministry of Education
- Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea
- MD-PhD/Medical Scientist Training Program, the Korea Health Industry Development Institute, Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Jeong, D. Y., Kim, C., Park, D., Kim, T., Ahn, S., Kim, B. J., & Kwon, S. U. (2026). A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease. Translational Stroke Research. https://doi.org/10.1007/s12975-026-01472-3
Vancouver
Jeong DY, Kim C, Park D, Kim T, Ahn S, Kim BJ, et al. A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease. Translational Stroke Research. 2026. doi:10.1007/s12975-026-01472-3
BibTeX
@article{Jeong2026,
author = {Jeong, Dong Young and Kim, Chulhong and Park, Dougho and Kim, Taeyeon and Ahn, Sungho and Kim, Bum Joon and Kwon, Sun U},
title = {A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease},
journal = {Translational Stroke Research},
year = {2026},
doi = {10.1007/s12975-026-01472-3}
}
EUVIMED